HW Wainwright Downgrades Aclaris to Neutral, Cites Disappointing Study Data (NASDAQ:ACRS)
ATU Images/The Image Bank via Getty Images HC Wainwright has downgraded Aclaris Therapeutics (NASDAQ:ACRS) to neutral, citing disappointing data from ...
ATU Images/The Image Bank via Getty Images HC Wainwright has downgraded Aclaris Therapeutics (NASDAQ:ACRS) to neutral, citing disappointing data from ...